Stilwell Withdraws Director Nomination After Board Appointment, Presses Ahead with Share Repurchase Proxy Fight
CPBI sits 29% above its 52-week low of $14.52.
Summary
Stilwell Group withdrew its director nomination after Central Plains Bancshares appointed its candidate to the board, but the activist will continue its proxy fight for a mandatory share repurchase program.
Key Events · Ownership and Investor Activity · CPBI
-
Director Nomination Withdrawn After Board Appointment
Stilwell Group withdrew its nomination of Francis Younes and alternate Mark Novotny for the 2026 annual meeting after Central Plains Bancshares appointed Younes to its board on July 9, 2026, as disclosed in a concurrent 8-K.
-
Share Repurchase Proxy Fight Continues
Stilwell will proceed with soliciting votes for its non-binding proposal that the board repurchase at least 10% of outstanding shares annually when the stock trades below book value per share.
-
Stake Remains at 9.7%
The group continues to beneficially own 406,874 shares, or 9.7% of the 4,182,777 shares outstanding as of June 18, 2026, with no purchases or sales since the last amendment.
-
Activist History and Strategy
Stilwell has a long track record of pushing community banks to repurchase shares or sell themselves; its campaign at Central Plains Bancshares is part of a broader strategy to unlock value in undervalued financial institutions.
Analysis · CPBI · Finance
Activist investor Stilwell Group has withdrawn its director nomination after Central Plains Bancshares appointed its candidate, Francis Younes, to the board — a significant concession that resolves one front of the proxy battle. However, Stilwell is not backing down entirely: it will continue to solicit votes for its non-binding proposal requiring the company to repurchase at least 10% of its shares annually whenever the stock trades below book value. With the stock near its 52-week high but still below book value, the proposal could force a meaningful return of capital to shareholders. The filing confirms Stilwell's 9.7% stake remains unchanged, and the group retains its activist posture, signaling ongoing pressure on management to enhance shareholder value.
At the time of this filing, CPBI was trading at $18.78 on NASDAQ in the Finance sector, with a market capitalization of approximately $78.6M. The 52-week trading range was $14.52 to $19.25. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.